MARKET

LABFF

LABFF

LABORATORIOS FAR
OTCMKTS

Real-time Quotes | Nasdaq Last Sale

68.75
0.00
0.00%
Closed 16:00 10/15 EDT
OPEN
--
PREV CLOSE
68.75
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
71.07
52 WEEK LOW
49.58
MARKET CAP
3.81B
P/E (TTM)
38.94
1D
5D
1M
3M
1Y
5Y
UPDATE 2-Moderna to recall COVID-19 doses in Japan after stainless steel contaminants found
UPDATE 2-Moderna to recall COVID-19 doses in Japan after stainless steel contaminants found
reuters.com · 09/01 13:47
UPDATE 1-Japan finds stainless steel particles in suspended doses of Moderna vaccine
reuters.com · 09/01 13:47
Japan finds stainless steel particles in suspended Moderna shots, health risk low
reuters.com · 09/01 12:10
Japan finds another Moderna vial suspected to contain foreign substance
reuters.com · 09/01 00:31
UPDATE 3-Japan's Moderna vaccine contamination woes widen as regions put holds on more shots
reuters.com · 08/30 07:08
Japan's Gunma prefecture reports contaminant in Moderna COVID-19 vaccine
reuters.com · 08/30 01:40
EU says Moderna COVID vaccine production can continue after contamination incident
reuters.com · 08/27 13:53
Rovi investigating possible Moderna vaccine contamination, no safety issues so far
reuters.com · 08/26 16:10
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of LABFF. Analyze the recent business situations of LABORATORIOS FAR through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 10 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

50.00%Strong Buy
50.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average LABFF stock price target is 76.03 with a high estimate of 82.94 and a low estimate of 55.10.
High82.94
Average76.03
Low55.10
Current 68.75
EPS
Actual
Estimate
0.130.260.380.51
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Institutional Holdings
Institutions: 0
Institutional Holdings: 0
% Owned: 0.00%
Shares Outstanding: 55.38M
TypeInstitutionsShares
Increased
0
0
New
0
0
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.52%
Pharmaceuticals & Medical Research
+0.11%
Key Executives
Chairman/Director
Juan Lopez-Belmonte Lopez
Chief Executive Officer/Executive Director
Juan Lopez-Belmonte Encina
Vice Chairman/Chief Financial Officer/Executive Director/Director
Javier Lopez-Belmonte Encina
Vice Chairman/Vice President - Business Development/Executive Director/Director
Ivan Jorge Lopez-Belmonte Encina
Chief Administrative Officer
Pablo Dominguez Jorge
Director of Human Resources
Francisco Javier Angulo Garcia
Other
Pedro Carretero Trillo
Other
Miguel Angel Castillo Roman
Other
Jose Eduardo Gonzalez Martinez
Other
Ibon Gutierro Aduriz
Other
Aranzazu Lozano Pirrongelli
Other
Fernando Martinez Morales
Other
Maite Munoz Pineda
Other
Miguel Angel Ortega Sanchez
Secretary
Gabriel Nunez Fernandez
Independent Director
Enrique Castellon Leal
Independent Director
Miguel Corsini Freese
Independent Director
Jose Fernando de Almansa Moreno-Barreda
Declaration Date
Dividend Per Share
Ex-Div Date
--
Dividend EUR 0.308772
07/02/2021
About LABFF
Laboratorios Farmaceuticos ROVI SA (ROVI) is a Spain-based company principally engaged in the pharmaceutical industry. The Company’s main activities include the development and commercialization, nationwide and abroad, of medicines and drugs. Its products are structured into three fields: Diagnostic, which offers contrast mediums for use in magnetic resonance, ultrasound and X-ray diagnostics; Prescription, which distributes medicines under such brands as Hibor, Osseor, Hepadren, Pneumovax-23, Glufan, Corlentor, Exxiv, Calcio y Vitamina D3 Rovi and Absorcol, among others; and Over The Counter (OTC), which comprises the Perspirex, Enerzona, Dentimelo and ColdPack brands. The Company owns such fully consolidated subsidiaries as Gineladius SL, Frosst Iberica SA, Rovi Contract Manufacturing SL and Bertex Pharma GmbH, among others.

Webull offers kinds of Laboratorios Farmaceuticos ROVI SA stock information, including OTCMKTS:LABFF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LABFF stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LABFF stock methods without spending real money on the virtual paper trading platform.